Early LabsEarly Labs
Early Labs

Early Labs

Pioneering volatile markers (VM) tests for early cancer detection in large-scale populations.

Website
2017Active7
Advertise here

About

Early Labs is developing a novel, proprietary multi-cancer screening platform that utilizes Volatile Organic Compound (VOC) biomarkers for early cancer detection. Their Biosensor Platform (BSP) Urine Test aims to make cancer screening accurate, accessible, affordable, and acceptable for patients, payers, policymakers, and providers. This non-invasive, self-administered test seeks to increase survival rates and improve quality of life by identifying cancer at its earliest stages.

Technology stack

detected 2026-06-10
Est. monthly stack spend~$140/mo
EmailMicrosoft 365
Hosting
self_managed
Stack
jQueryWordPress
SEO
Yoast SEO
Comments

No comments yet. Be the first to share your take.

Frequently asked

What does Early Labs do?

Early Labs is developing a novel, proprietary multi-cancer screening platform that utilizes Volatile Organic Compound (VOC) biomarkers for early cancer detection. Their Biosensor Platform (BSP) Urine Test aims to make cancer screening accurate, accessible, affordable, and acceptable for patients, payers, policymakers, and providers. This non-invasive, self-administered test seeks to increase survival rates and improve quality of life by identifying cancer at its earliest stages.

How much funding has Early Labs raised?

Early Labs has raised a total of $10M in funding. The most recent round on record is Seed.

Where is Early Labs headquartered?

Early Labs is headquartered in Tel Aviv, Israel.

When was Early Labs founded?

Early Labs was founded in 2017.

What industry does Early Labs operate in?

Early Labs operates in Healthcare, Oncology, Detection, Urine, Diagnostics, HealthTech.

How many employees does Early Labs have?

Early Labs has approximately 7 people on record.